Implanted Wireless Glucose Sensor That Could Transform Management Of Diabetes Passes Crucial TestThursday, July 29, 2010 @ 7:20AMAmerican bioengineers have demonstrated that an implanted glucose sensor with potential to transform the management of diabetes has passed a crucial test: the device they developed worked continuously in animals for over a year, without showing signs of "tissue encapsulation" seen in trials with other similar devices...
More Adults With Diabetes Are Getting Flu ShotsSaturday, April 10, 2010 @ 6:34AMThe proportion of Americans with diabetes ages 18 to 64 who reported getting flu shots the previous year rose from 40 percent to 50.5 percent between 2000 and 2007, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. In contrast, the proportion of seniors ages 65 and older with diabetes who reported getting a flu shot within the previous year remained ...
Bone Marrow Cells Produce Nerve Growth Factor And Promote Angiogenesis Around Transplanted IsletsFriday, April 2, 2010 @ 8:18AMIslet transplantation is a promising treatment for type 1 diabetes mellitus. The promotion of angiogenesis is an important endeavor to prevent islet graft failure. Endothelial precursor cells (EPCs), a heterogeneous group originating in the hematopoietic compartment of bone marrow, have an important role in the angiogenesis of adult tissues. Transplanted EPCs induce hypoxia-inducible factor-1α ...
Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular EventsWednesday, March 31, 2010 @ 4:58PMBackground The ability of short-acting insulin secretagogues to reduce the risk of diabetes or cardiovascular events in people with impaired glucose tolerance is unknown. Methods In a double-blind, randomized clinical ...
New Insight Into Diabetes From Sea-Creatures' Sex ProteinTuesday, March 23, 2010 @ 10:35AMA genetic accident in the sea more than 500 million years ago has provided new insight into diabetes, according to research from Queen Mary, University of London. Professor Maurice Elphick, from Queen Mary's School of Biological and Chemical Sciences, says his findings could help to explain a rare form of the disease that causes sufferers to urinate more than three litres every day. As reported ...
Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular EventsWednesday, March 17, 2010 @ 4:59PMBackground The ability of short-acting insulin secretagogues to reduce the risk of diabetes or cardiovascular events in people with impaired glucose tolerance is unknown. Methods In a double-blind, randomized clinical ...
Drug Helps Diabetics, Trial FindsMonday, March 15, 2010 @ 4:18PMA generic anti-inflammatory drug from the aspirin family helped patients in a clinical trial lower their blood sugar.
Novo Nordisk Makes Victoza(R) Commercially Available in the United StatesTuesday, February 16, 2010 @ 7:11AMPRINCETON, NJ--(Marketwire - February 16, 2010) - Novo Nordisk ( NYSE : NVO ) today announced that Victoza® (liraglutide [rDNA origin] injection) is now available in the United States. Victoza is the first once-daily human glucagon-like peptide-1 (GLP-1) analog for the treatment of type 2 diabetes. It is indicated in the U.S. as an adjunct to diet and exercise to improve blood sugar control in ...
Novo Nordisk Makes Victoza(R) Commercially Available in the United StatesTuesday, February 16, 2010 @ 7:00AMNovo Nordisk today announced that Victoza® is now available in the United States. Victoza is the first once-daily human glucagon-like peptide-1 analog for the treatment of type 2 diabetes.  It is indicated in the U.S. as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes.  Victoza can be used alone as well as in combination with other oral anti ...